411
Participants
Start Date
March 4, 2021
Primary Completion Date
May 13, 2022
Study Completion Date
May 30, 2022
Apixaban 2.5 MG
Apixaban 2.5mg twice daily for 30 days
Placebo
placebo twice daily for 30 days
Hospital Maternidade São Vicente de Paulo, Barbalha
Hospital Universitário São Francisco de Assis, Bragança Paulista
Hospital Israelita Albert Einstein, São Paulo
Hospital Santa Paula, São Paulo
Lead Sponsor
Hospital Israelita Albert Einstein
OTHER
Hospital do Coracao
OTHER
Hospital Sirio-Libanes
OTHER
Hospital Moinhos de Vento
OTHER
Hospital Alemão Oswaldo Cruz
OTHER
Beneficência Portuguesa de São Paulo
OTHER
Brazilian Research In Intensive Care Network
NETWORK
Brazilian Clinical Research Institute
OTHER